2015 Q2 Form 10-Q Financial Statement

#000093454915000040 Filed on August 10, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2 2014 Q1
Revenue $40.34M $50.08M $12.58M
YoY Change -19.45% 116.69% -83.64%
Cost Of Revenue $1.270M $10.69M $950.0K
YoY Change -88.12% 90.55% -94.86%
Gross Profit $39.07M $39.38M $11.63M
YoY Change -0.79% 125.03% -80.08%
Gross Profit Margin 96.86% 78.64% 92.46%
Selling, General & Admin $15.10M $20.26M $13.22M
YoY Change -25.47% 17.72% -54.22%
% of Gross Profit 38.65% 51.45% 113.67%
Research & Development $730.0K $1.000M $990.0K
YoY Change -27.0% 36.99% -2.94%
% of Gross Profit 1.87% 2.54% 8.51%
Depreciation & Amortization $13.30M $15.60M $14.55M
YoY Change -14.74% 23.81% 23.59%
% of Gross Profit 34.04% 39.61% 125.12%
Operating Expenses $29.06M $36.80M $28.69M
YoY Change -21.03% 20.62% -31.1%
Operating Profit $1.000M -$8.231M -$26.05M
YoY Change -112.15% -64.1% -467.17%
Interest Expense -$100.0K -$200.0K $110.0K
YoY Change -50.0% -150.0% -91.47%
% of Operating Profit -10.0%
Other Income/Expense, Net -$104.0K -$196.0K $109.0K
YoY Change -46.94% -149.0% -91.55%
Pretax Income $896.0K -$8.427M -$25.94M
YoY Change -110.63% -62.6% -409.39%
Income Tax $119.0K $4.689M -$1.372M
% Of Pretax Income 13.28%
Net Earnings -$3.686M -$12.95M -$24.42M
YoY Change -71.53% 3.57% -577.63%
Net Earnings / Revenue -9.14% -25.86% -194.16%
Basic Earnings Per Share -$0.08 -$0.27 -$0.51
Diluted Earnings Per Share -$0.08 -$0.27 -$0.51
COMMON SHARES
Basic Shares Outstanding 49.42M shares 48.54M shares 48.33M shares
Diluted Shares Outstanding 49.42M shares 48.54M shares 48.33M shares

Balance Sheet

Concept 2015 Q2 2014 Q2 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $156.2M $220.8M $229.0M
YoY Change -29.26% -31.02% -30.05%
Cash & Equivalents $119.1M $146.0M $146.0M
Short-Term Investments $37.10M $74.80M $95.60M
Other Short-Term Assets $17.00M $8.900M $10.70M
YoY Change 91.01% 4.71% 109.8%
Inventory
Prepaid Expenses
Receivables $37.55M $25.19M $13.54M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $210.7M $255.0M $253.3M
YoY Change -17.34% -26.18% -32.97%
LONG-TERM ASSETS
Property, Plant & Equipment $374.0K $701.0K $782.0K
YoY Change -46.65% 15.49% 45.9%
Goodwill $30.15M $30.15M $30.15M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $355.0K $350.0K $309.0K
YoY Change 1.43% -64.5% 123.91%
Total Long-Term Assets $293.2M $313.7M $321.4M
YoY Change -6.54% -6.42% -4.51%
TOTAL ASSETS
Total Short-Term Assets $210.7M $255.0M $253.3M
Total Long-Term Assets $293.2M $313.7M $321.4M
Total Assets $504.0M $568.7M $574.7M
YoY Change -11.38% -16.44% -19.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.50M $16.80M $12.30M
YoY Change -31.55% 7.69% -28.07%
Accrued Expenses $0.00 $6.000M $19.30M
YoY Change -100.0% -7.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $31.71M $43.10M $35.44M
YoY Change -26.44% 2.41% -34.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $271.0K $319.0K $319.0K
YoY Change -15.05% -86.27% -35.43%
Total Long-Term Liabilities $271.0K $319.0K $319.0K
YoY Change -15.05% -86.27% -35.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $31.71M $43.10M $35.44M
Total Long-Term Liabilities $271.0K $319.0K $319.0K
Total Liabilities $33.14M $46.63M $39.51M
YoY Change -28.93% -24.42% -51.93%
SHAREHOLDERS EQUITY
Retained Earnings -$144.9M -$99.44M -$86.49M
YoY Change 45.73% 663.6% 16564.16%
Common Stock $51.00K $50.00K $50.00K
YoY Change 2.0% 0.0% 2.04%
Preferred Stock
YoY Change
Treasury Stock (at cost) $34.64M $34.64M $34.64M
YoY Change 0.0% 29.59% 29.59%
Treasury Stock Shares 1.729M shares 1.729M shares 1.729M shares
Shareholders Equity $461.3M $516.2M $528.9M
YoY Change
Total Liabilities & Shareholders Equity $504.0M $568.7M $574.7M
YoY Change -11.38% -16.44% -19.57%

Cashflow Statement

Concept 2015 Q2 2014 Q2 2014 Q1
OPERATING ACTIVITIES
Net Income -$3.686M -$12.95M -$24.42M
YoY Change -71.53% 3.57% -577.63%
Depreciation, Depletion And Amortization $13.30M $15.60M $14.55M
YoY Change -14.74% 23.81% 23.59%
Cash From Operating Activities $9.400M $19.80M -$20.43M
YoY Change -52.53% 1423.08% -221.44%
INVESTING ACTIVITIES
Capital Expenditures -$1.800M -$21.10M $96.00K
YoY Change -91.47% 817.39% -60.17%
Acquisitions
YoY Change
Other Investing Activities $16.30M $21.00M $34.40M
YoY Change -22.38% -156.45% -178.18%
Cash From Investing Activities $14.60M -$100.0K $33.32M
YoY Change -14700.0% -99.75% -169.1%
FINANCING ACTIVITIES
Cash Dividend Paid $6.255M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.400M -7.000M -$6.165M
YoY Change -8.57% 20.69% -324.51%
NET CHANGE
Cash From Operating Activities 9.400M 19.80M -$20.43M
Cash From Investing Activities 14.60M -100.0K $33.32M
Cash From Financing Activities -6.400M -7.000M -$6.165M
Net Change In Cash 17.60M 12.70M $6.718M
YoY Change 38.58% -128.73% -123.45%
FREE CASH FLOW
Cash From Operating Activities $9.400M $19.80M -$20.43M
Capital Expenditures -$1.800M -$21.10M $96.00K
Free Cash Flow $11.20M $40.90M -$20.53M
YoY Change -72.62% 1036.11% -223.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
actg Acceleratedamortizationexpenseterminationsale
Acceleratedamortizationexpenseterminationsale
2702000 USD
CY2014Q4 actg Accrued Patent Acquisition Related Payments Current
AccruedPatentAcquisitionRelatedPaymentsCurrent
16700000 USD
CY2015Q2 actg Accrued Patent Acquisition Related Payments Current
AccruedPatentAcquisitionRelatedPaymentsCurrent
0 USD
CY2014Q2 actg Contingent Legal Fees
ContingentLegalFees
7077000 USD
actg Contingent Legal Fees
ContingentLegalFees
8604000 USD
CY2015Q2 actg Contingent Legal Fees
ContingentLegalFees
5512000 USD
actg Contingent Legal Fees
ContingentLegalFees
10296000 USD
CY2014Q2 actg Dividendsattributabletocommonstockholdersunderthetwoclassmethod
Dividendsattributabletocommonstockholdersunderthetwoclassmethod
-6053000 USD
actg Dividendsattributabletocommonstockholdersunderthetwoclassmethod
Dividendsattributabletocommonstockholdersunderthetwoclassmethod
-12102000 USD
CY2015Q2 actg Dividendsattributabletocommonstockholdersunderthetwoclassmethod
Dividendsattributabletocommonstockholdersunderthetwoclassmethod
-6164000 USD
actg Dividendsattributabletocommonstockholdersunderthetwoclassmethod
Dividendsattributabletocommonstockholdersunderthetwoclassmethod
-12324000 USD
actg Gainon Patent Sale
GainonPatentSale
833000 USD
actg Increase Decrease In Royalties And Contingent Legal Fees Payable
IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable
9865000 USD
actg Increase Decrease In Royalties And Contingent Legal Fees Payable
IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable
5830000 USD
CY2014Q2 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
10820000 USD
actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
19814000 USD
CY2015Q2 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
9012000 USD
actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
17687000 USD
actg Patent Acquisition Costs Included In Accrued Expenses
PatentAcquisitionCostsIncludedInAccruedExpenses
3000000 USD
actg Patent Acquisition Costs Included In Accrued Expenses
PatentAcquisitionCostsIncludedInAccruedExpenses
0 USD
CY2014Q4 actg Patents Accumulated Amortization
PatentsAccumulatedAmortization
166565000 USD
CY2015Q2 actg Patents Accumulated Amortization
PatentsAccumulatedAmortization
192831000 USD
CY2014Q4 actg Patents Net Of Accumulated Amortization
PatentsNetOfAccumulatedAmortization
286636000 USD
CY2015Q2 actg Patents Net Of Accumulated Amortization
PatentsNetOfAccumulatedAmortization
262337000 USD
actg Proceeds From Patent Sale
ProceedsFromPatentSale
3500000 USD
CY2014Q2 actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
1003000 USD
actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
1995000 USD
CY2015Q2 actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
732000 USD
actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
1729000 USD
CY2014Q4 actg Royalties And Contingent Legal Fees Payable
RoyaltiesAndContingentLegalFeesPayable
14351000 USD
CY2015Q2 actg Royalties And Contingent Legal Fees Payable
RoyaltiesAndContingentLegalFeesPayable
20181000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000934549
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50740195 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
ACACIA RESEARCH CORP
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
14860000 USD
CY2015Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11525000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20168000 USD
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
37550000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-353000 USD
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-413000 USD
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P6Y
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
646595000 USD
CY2015Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
641207000 USD
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15532000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
30004000 USD
CY2015Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13228000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
26266000 USD
CY2014Q4 us-gaap Assets
Assets
536348000 USD
CY2015Q2 us-gaap Assets
Assets
503964000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
218708000 USD
CY2015Q2 us-gaap Assets Current
AssetsCurrent
210749000 USD
CY2014Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
58558000 USD
CY2015Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
37090000 USD
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
58819000 USD
CY2015Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
37270000 USD
CY2014 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
2000 USD
us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
10000 USD
CY2014 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
263000 USD
us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
190000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
126685000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
146040000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
134466000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
119084000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
19355000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-15382000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.125
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.250
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50065382 shares
CY2015Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.125
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.250
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50979582 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50065382 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50979582 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
50000 USD
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
51000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12757000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37207000 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3659000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16876000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-12924000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-37523000 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
804000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-12835000 USD
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1161000 USD
CY2015Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1161000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1161000 USD
CY2015Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1161000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30166000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26386000 USD
CY2014Q2 us-gaap Dividends
Dividends
6258000 USD
us-gaap Dividends
Dividends
12513000 USD
CY2015Q2 us-gaap Dividends
Dividends
6374000 USD
us-gaap Dividends
Dividends
12749000 USD
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.78
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2014Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.56
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.10
CY2015Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.13
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.02
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
54350000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
26080000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
38917000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
44549000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
48676000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
49765000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
262337000 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13181000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24874000 USD
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9587000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20162000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
30149000 USD
CY2015Q2 us-gaap Goodwill
Goodwill
30149000 USD
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2565000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3317000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8427000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34369000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
896000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12486000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4689000 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
119000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
289000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5736000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3292000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18844000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17382000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1668000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1724000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
791000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
10718000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
47300000 USD
CY2015Q2 us-gaap Liabilities
Liabilities
33138000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
536348000 USD
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
503964000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
45911000 USD
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
31706000 USD
CY2014Q2 us-gaap Licenses Revenue
LicensesRevenue
50076000 USD
us-gaap Licenses Revenue
LicensesRevenue
62654000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-639000 USD
CY2015Q2 us-gaap Licenses Revenue
LicensesRevenue
40336000 USD
us-gaap Licenses Revenue
LicensesRevenue
74546000 USD
us-gaap Line Of Credit Facility Commitment Fee Percentage
LineOfCreditFacilityCommitmentFeePercentage
0.0115
CY2014Q4 us-gaap Minority Interest
MinorityInterest
5491000 USD
CY2015Q2 us-gaap Minority Interest
MinorityInterest
9532000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13195000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11811000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
33189000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2874000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6445000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-12949000 USD
us-gaap Net Income Loss
NetIncomeLoss
-37370000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-3686000 USD
us-gaap Net Income Loss
NetIncomeLoss
-16816000 USD
CY2014Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-167000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-316000 USD
CY2015Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4463000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4041000 USD
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13154000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-37781000 USD
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3896000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17241000 USD
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-13154000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-37781000 USD
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3896000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-17241000 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-196000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-87000 USD
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-104000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
124000 USD
CY2014Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
58307000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
96936000 USD
CY2015Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
39336000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
87156000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8231000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-34282000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-12610000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
355000 USD
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
355000 USD
CY2014Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
0 USD
CY2015Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-113000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-141000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-565000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-1012000 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-259000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-343000 USD
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-373000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-849000 USD
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-119000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-262000 USD
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
CY2014Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
0 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
0 USD
CY2015Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
0 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
426000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
228000 USD
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
271000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-127000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
12513000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
12749000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
33359000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
23296000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
22096000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
18667000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
97000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
867000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4355000 USD
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5146000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
88741000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
44845000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
185000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
938000 USD
CY2014Q2 us-gaap Profit Loss
ProfitLoss
-13116000 USD
us-gaap Profit Loss
ProfitLoss
-37686000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
500000 USD
CY2015Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10718000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128095000 USD
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-144911000 USD
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49423472 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49318423 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48543334 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48436946 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49423472 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49318423 shares
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
374000 USD
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 USD
CY2015Q2 us-gaap Profit Loss
ProfitLoss
777000 USD
us-gaap Profit Loss
ProfitLoss
-12775000 USD
CY2014Q2 us-gaap Royalty Expense
RoyaltyExpense
10694000 USD
us-gaap Royalty Expense
RoyaltyExpense
11645000 USD
CY2015Q2 us-gaap Royalty Expense
RoyaltyExpense
1265000 USD
us-gaap Royalty Expense
RoyaltyExpense
10590000 USD
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5303000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10068000 USD
CY2015Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3177000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6424000 USD
CY2014Q4 us-gaap Short Term Investments
ShortTermInvestments
58558000 USD
CY2015Q2 us-gaap Short Term Investments
ShortTermInvestments
37090000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
483557000 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
461294000 USD
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
489048000 USD
CY2015Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
470826000 USD
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1729408 shares
CY2015Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
1729408 shares
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
34640000 USD
CY2015Q2 us-gaap Treasury Stock Value
TreasuryStockValue
34640000 USD
CY2014Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2015Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48543334 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48436946 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentrations. </font><font style="font-family:inherit;font-size:10pt;">One</font><font style="font-family:inherit;font-size:10pt;"> licensee individually accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">74%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the three months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;text-decoration:none;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> licensees accounted for </font><font style="font-family:inherit;font-size:10pt;">40%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">27%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the six months ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">. Two licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;">58%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">14%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the three months ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">, and two licensees accounted for </font><font style="font-family:inherit;font-size:10pt;">46%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the </font><font style="font-family:inherit;font-size:10pt;">six months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">One licensee individually represented approximately </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">80%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;text-decoration:none;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">. The majority of accounts receivable balances at June 30, 2015 were collected in July 2015. Three licensees individually represented approximately </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">30%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">17%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at December 31, 2014. For the </font><font style="font-family:inherit;font-size:10pt;">three and six months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">18%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">38%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. For the </font><font style="font-family:inherit;font-size:10pt;">three and six months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">79%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">67%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions. The Company does not have any material foreign operations.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates.&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, stock-based compensation expense, impairment of marketable securities and intangible assets including goodwill, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets and the application of the acquisition method of accounting for business combinations, require its most difficult, subjective or complex judgments.</font></div></div>

Files In Submission

Name View Source Status
0000934549-15-000040-index-headers.html Edgar Link pending
0000934549-15-000040-index.html Edgar Link pending
0000934549-15-000040.txt Edgar Link pending
0000934549-15-000040-xbrl.zip Edgar Link pending
actg-20150630.xml Edgar Link completed
actg-20150630.xsd Edgar Link pending
actg-20150630_cal.xml Edgar Link unprocessable
actg-20150630_def.xml Edgar Link unprocessable
actg-20150630_lab.xml Edgar Link unprocessable
actg-20150630_pre.xml Edgar Link unprocessable
actg10q06302015.htm Edgar Link pending
ex31106302015.htm Edgar Link pending
ex31206302015.htm Edgar Link pending
ex32106302015.htm Edgar Link pending
ex32206302015.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
graphicactga02a01.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending